0001401708-24-000092.txt : 20240508 0001401708-24-000092.hdr.sgml : 20240508 20240508204953 ACCESSION NUMBER: 0001401708-24-000092 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240506 FILED AS OF DATE: 20240508 DATE AS OF CHANGE: 20240508 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BEECHEM JOSEPH M CENTRAL INDEX KEY: 0001576195 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35980 FILM NUMBER: 24928176 MAIL ADDRESS: STREET 1: 530 FAIRVIEW AVENUE NORTH STREET 2: SUITE 2000 CITY: SEATTLE STATE: WA ZIP: 98109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NanoString Technologies Inc CENTRAL INDEX KEY: 0001401708 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 200094687 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 530 FAIRVIEW AVENUE NORTH CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 206-378-6266 MAIL ADDRESS: STREET 1: 530 FAIRVIEW AVENUE NORTH CITY: SEATTLE STATE: WA ZIP: 98109 4 1 wk-form4_1715215780.xml FORM 4 X0508 4 2024-05-06 1 0001401708 NanoString Technologies Inc NSTG 0001576195 BEECHEM JOSEPH M 530 FAIRVIEW AVENUE N SEATTLE WA 98109 0 1 0 0 SVP, Research & Development 0 Common Stock 2024-05-06 4 M 0 8460 0 A 149550 D Common Stock 2024-05-06 4 M 0 104545 0 A 254095 D Common Stock 2024-05-06 4 M 0 34848 0 A 288943 D Restricted Stock Units 2024-05-06 4 M 0 8460 0 D Common Stock 8460 0 D Restricted Stock Units 2024-05-06 4 M 0 69697 0 D Common Stock 69697 0 D Performance Restricted Stock Units 2024-05-06 4 M 0 104545 0 D Common Stock 104545 0 D The shares have not been delivered to the reporting person. Each RSU represents a contingent right to receive one (1) share of Issuer's common stock. Pursuant to the terms of the award, as a result of the closing of the sale of substantially all of the assets of the Company to Bruker Corporation, which constituted a Change of Control under the terms of the RSU award agreement, the vesting of the RSUs accelerated. Each Performance Restricted Stock Unit ("PSU") represents a contingent right to receive one (1) share of Issuer's common stock. Pursuant to the terms of the award, as a result of the closing of the sale of substantially all of the assets of the Company to Bruker Corporation, which constituted a Change of Control under the terms of the PSU award agreement, the vesting of the PSUs accelerated. /s/ Shannon Atchison, Attorney in Fact 2024-05-08